The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and radiographic characteristics of patients with metastatic breast cancer and pseudocirrhosis: A single-center retrospective cohort study.
 
Laura Ann Huppert
No Relationships to Disclose
 
Zak Walker
No Relationships to Disclose
 
Moming Li
No Relationships to Disclose
 
Mi-Ok Kim
No Relationships to Disclose
 
Jennie Callan
No Relationships to Disclose
 
Melanie Majure
No Relationships to Disclose
 
Michelle E. Melisko
Stock and Other Ownership Interests - Merrimack (I)
Honoraria - Genentech (I)
Speakers' Bureau - Genentech (I)
Research Funding - KCRN Research (Inst); Novartis (Inst); OBI Pharma (Inst); Puma Biotechnology (Inst); Seagen (Inst)
 
Hope S. Rugo
Honoraria - Mylan; Puma Biotechnology; Samsung Bioepis
Consulting or Advisory Role - Napo Pharmaceuticals
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
 
Spencer Behr
Consulting or Advisory Role - Advanced Accelerator Applications; GenVivo; More Health; Progenics
Research Funding - Cancer Targeted Technology
 
Amy Jo Chien
Honoraria - bioTheranostics; sanofi
Consulting or Advisory Role - Novartis; Seagen
Research Funding - Amgen (Inst); Merck (Inst); Puma Biotechnology (Inst); Seagen (Inst)